| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.06M | 7.00M | 7.35M | 14.59M | 20.93M | 24.63M |
| Gross Profit | 1.31M | 1.47M | 1.61M | 2.51M | 2.64M | 3.42M |
| EBITDA | -4.33M | -2.55M | -3.23M | 5.39M | -5.01M | -8.58M |
| Net Income | -3.53M | -2.65M | -3.31M | 7.27M | -4.93M | -6.38M |
Balance Sheet | ||||||
| Total Assets | 16.90M | 15.24M | 21.40M | 24.25M | 30.22M | 33.52M |
| Cash, Cash Equivalents and Short-Term Investments | 10.09M | 8.86M | 16.37M | 11.92M | 5.66M | 4.51M |
| Total Debt | 1.98M | 1.49M | 3.20M | 4.40M | 6.12M | 11.83M |
| Total Liabilities | 7.13M | 7.29M | 9.15M | 9.15M | 23.14M | 19.59M |
| Stockholders Equity | 11.02M | 9.05M | 12.70M | 14.88M | 7.80M | 12.53M |
Cash Flow | ||||||
| Free Cash Flow | -3.51M | -2.97M | -754.00K | -1.25M | -35.00K | -4.67M |
| Operating Cash Flow | -2.94M | -2.40M | -456.00K | -1.17M | 238.00K | -3.98M |
| Investing Cash Flow | -2.89M | -3.23M | 3.82M | 11.77M | -267.00K | -578.00K |
| Financing Cash Flow | 6.95M | -1.88M | 1.12M | -4.82M | 1.91M | 5.65M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | S$28.08M | 4.59 | 14.32% | 1.22% | 33.55% | 2595.24% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | S$16.87M | 12.50 | 3.08% | ― | -8.21% | ― | |
46 Neutral | S$39.49M | -1.70 | -19.55% | 0.92% | -7.45% | -480.22% | |
45 Neutral | S$49.71M | -2.12 | -20.85% | ― | -2.43% | 52.80% | |
37 Underperform | S$11.35M | -2.47 | -31.32% | ― | -20.15% | -2.30% |
Matex International Limited, a company incorporated in Singapore, has announced a change in its Board of Directors. Mr. James Kho Chung Wah, currently an Independent Director, will be re-designated as the Independent Chairman of the Board effective 26 November 2025. Despite this change, the company acknowledges its current non-compliance with certain corporate governance rules and aims to address these issues by filling board and committee vacancies within three months.
The most recent analyst rating on (SG:M15) stock is a Sell with a S$0.02 price target. To see the full list of analyst forecasts on Matex International Limited stock, see the SG:M15 Stock Forecast page.
Matex International Limited, a company incorporated in Singapore, has announced a significant legal expenditure of S$518,942.41 incurred over a 10-week period related to shareholder requisitions, lawsuits, and a settlement agreement. This expenditure represents approximately 93.5% of the company’s gross profit for the first half of 2025 and 5.3% of its net assets as of June 30, 2025. The Board is currently assessing the financial impact and seeking legal advice on the reasonableness of these expenses.
Matex International Limited, a company incorporated in Singapore, has received a letter of demand from Dr Tan Pang Kee and Mr Tan Guan Liang regarding cessation payments due under a settlement agreement. The letter demands payment by 18 November 2025, failing which legal action will be initiated. The company is seeking legal advice and will update shareholders as necessary.
Matex International Limited, a company incorporated in Singapore, has announced significant changes to its board and board committees, effective from November 5, 2025. The company appointed Mr. Chen Hongbo as the new CEO, while Dr. Danny Oh Beng Teck, Mr. Tan Chong Huat, and Mr. Yeo Hock Huat have resigned from their respective positions. These changes are seen as an opportunity for the company to reassess the size and composition of its board and committees, aligning with the Code of Corporate Governance 2018 and the Catalist Rules. The company plans to fill the vacancies within three months.
Matex International Limited has announced an update regarding its intended Extraordinary General Meeting (EGM) to seek shareholder approval for cessation payments to Dr Tan Pang Kee and Mr Tan Guan Liang. The Board plans to publish the notice for the EGM by December 19, 2025, aiming to hold the meeting in January 2026. The payments are classified as an ‘interested person transaction’ under Catalist Rules, and the company is working with legal advisors to ensure all relevant information is provided to shareholders.
Matex International Limited, a company incorporated in Singapore, has announced a change in its board of directors with the appointment of Dr. Liu Shen as Executive Director and Chief Technical Officer, effective from October 17, 2025. This appointment reflects the company’s strategic decision to strengthen its leadership team, although Dr. Liu Shen will not be part of any board committees, leaving the current committee compositions unchanged.
Matex International Limited held an Extraordinary General Meeting at the Suntec Singapore Convention & Exhibition Centre. The meeting was briefly adjourned to await announcements to the Singapore Exchange Securities Trading Limited, after which it resumed. The meeting introduced directors and proposed nominated directors, highlighting the company’s ongoing governance and strategic planning efforts.